Abstract
An antivirulence agent against Vibrio vulnificus named quoromycin (QM) was discovered by a phenotype-based elastase inhibitor screening. Using the fluorescence difference in two-dimensional gel electrophoresis (FITGE) approach, SmcR, a quorum-sensing master regulator and homologue of LuxR, was identified as the target protein of QM. We confirmed that the direct binding of QM to SmcR inhibits the quorum-sensing signaling pathway by controlling the DNA-binding affinity of SmcR and thus effectively alleviates the virulence of V. vulnificus in vitro and in vivo. QM can be regarded as a novel antivirulence agent for the treatment of V. vulnificus infection.
| Original language | English |
|---|---|
| Pages (from-to) | 3076-3082 |
| Number of pages | 7 |
| Journal | ACS Infectious Diseases |
| Volume | 6 |
| Issue number | 11 |
| DOIs | |
| State | Published - 13 Nov 2020 |
Bibliographical note
Publisher Copyright:©
Keywords
- antivirulence agent
- quorum sensing
- SmcR
- target identification
- Vibrio vulnificus